Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.

Détails

ID Serval
serval:BIB_3FA288C9277D
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Different impact of rATG induction on CMV infection risk in D+R- and R+ KTRs.
Périodique
The Journal of infectious diseases
Auteur(s)
Kaminski H., Jarque M., Halfon M., Taton B., Di Ascia L., Pfirmann P., Visentin J., Garrigue I., Déchanet-Merville J., Moreau J.F., Crespo E., Montero N., Melilli E., Meneghini M., Pascual M., Couzi L., Manuel O., Bestard O., Merville P.
ISSN
1537-6613 (Electronic)
ISSN-L
0022-1899
Statut éditorial
Publié
Date de publication
31/07/2019
Peer-reviewed
Oui
Volume
220
Numéro
5
Pages
761-771
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Rabbit antithymocyte globulin (rATG) induction is associated with profound immunosuppression, leading to a higher risk of cytomegalovirus (CMV) infection compared with anti-interleukin 2 receptor antibody (anti-IL-2RA). However, this risk, depending on the baseline CMV serological recipient/donor status, is still controversial.
The CMV DNAemia-free survival between rATG- and anti-IL-2RA-treated patients was analyzed in donor-positive/recipient-negative (D+R-) and recipient-positive (R+) patients in 1 discovery cohort of 559 kidney transplant recipients (KTRs) and 2 independent cohorts (351 and 135 kidney KTRs). The CMV-specific cell-mediated immunity (CMI) at baseline and at different time points after transplantation was assessed using an interferon γ enzyme-linked immunosorbent spot assay.
rATG increased the risk of CMV DNAemia in R+ but not in D+R- KTRs. In R+ CMI-positive (CMI+) patients, the CMV DNAemia rate was higher in rATG-treated than in anti-IL-2RA-treated patients; no difference was observed among R+ CMI-negative (CMI-) patients. Longitudinal follow-up demonstrated a deeper depletion of preformed CMV CMI in R+ rATG-treated patients.
D+R- KTRs have the highest risk of CMV DNAemia, but rATG adds no further risk. Among R+ KTRs, we described 3 groups, the least prone being R+CMI+ KTRs without rATG, then R+CMI+ KTRs with rATG, and finally R+CMI- KTRs. CMV serostatus, baseline CMV-specific CMI, and induction therapy may lead to personalized preventive therapy in further studies.
Mots-clé
anti–interleukin 2 receptor antibody, cytomegalovirus, kidney transplantation, rabbit antithymocyte globulin
Pubmed
Création de la notice
17/06/2019 16:42
Dernière modification de la notice
21/08/2019 5:34
Données d'usage